Targeting EML4-ALK gene fusion variant 3 in thyroid cancer

Finding targetable gene fusions can expand the limited treatment options in radioactive iodine-refractory (RAI-r) thyroid cancer. To that end, we established a novel cell line ‘JVE404’ derived from an advanced RAI-r papillary thyroid cancer (PTC) patient, harboring an EML4-ALK gene fusion variant 3...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Endocr Relat Cancer
Main Authors: Aydemirli, Mehtap Derya, van Eendenburg, Jaap D H, van Wezel, Tom, Oosting, Jan, Corver, Willem E, Kapiteijn, Ellen, Morreau, Hans
Formato: Artigo
Idioma:Inglês
Publicado em: Bioscientifica Ltd 2021
Assuntos:
Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC8183637/
https://ncbi.nlm.nih.gov/pubmed/33878728
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1530/ERC-20-0436
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados